Search images on Google      Product Monograph

Active Ingredients:

• c1 esterase inhibitor (human), 3000 UNIT/VIAL

DIN: 02468077

Dosage Form(s): KIT, POWDER FOR SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: FOR SUBCUTANEOUS ADMINISTRATION ONLY - SINGLE USE VIAL & DILUENT

Schedule: Schedule D

Company: CSL BEHRING CANADA INC

ATC:

• B06 - OTHER HEMATOLOGICAL AGENTS (ATC, WHO, Wiki)
• B06A - OTHER HEMATOLOGICAL AGENTS (ATC, WHO)
• B06AC - (ATC, WHO)
• B06AC01 - C1-INHIBITOR, PLASMA DERIVED (WHO)

Reference brand drug: Berinert

Pharmaceutical standard: MFR

 

External Links for Haegarda:

Search on Google

• Haegarda side effects
• Haegarda dosage
• c1 esterase inhibitor side effects
• c1 esterase inhibitor dosage